Page last updated: 2024-08-21

thiazoles and lamivudine

thiazoles has been researched along with lamivudine in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (70.00)	18.2507
2000's	1 (10.00)	29.6817
2010's	2 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Phillips, L	1
Chang, HE	1
Smart, T	2
Alcorn, K	1
Gao, LL; Li, Y; Lin, JS; Wang, XY; Zhang, YH	1
Arzumanyan, A; Clayton, MM; Feitelson, MA; Goldmann, S; Li, J; Liu, B; Ren, Q; Schinazi, RF; Wang, Z; Wu, G; Zhang, F; Zhang, Y	1
Lomonosova, E; Tavis, JE; Zlotnick, A	1

Trials

1 trial(s) available for thiazoles and lamivudine

Article	Year
Treatment for primary infection. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:12 Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Cohort Studies; Controlled Clinical Trials as Topic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Placebos; Pyridines; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine	1995

Article

Year

Treatment for primary infection.

GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:12

Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Cohort Studies; Controlled Clinical Trials as Topic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Placebos; Pyridines; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine

1995

Other Studies

9 other study(ies) available for thiazoles and lamivudine

Article	Year
New drugs for HIV infection. The Medical letter on drugs and therapeutics, 1996, Apr-12, Volume: 38, Issue:972 Topics: Antiviral Agents; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Zalcitabine	1996
Antiretroviral drugs: new agents, new combinations line up against HIV. Hospital technology series, 1996, Volume: 15, Issue:1 Topics: Antiviral Agents; Australia; Didanosine; Drug Therapy, Combination; Europe; HIV; HIV Infections; Humans; Lamivudine; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ritonavir; Thiazoles; United States; Valine; Zalcitabine; Zidovudine	1996
Conference looks at HIV drug resistance. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:9 Topics: Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Microbial; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine; Viremia; Zalcitabine; Zidovudine	1995
Protease inhibitors shine in triple combinations. AIDS alert, 1996, Volume: 11, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Pyridines; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine	1996
Europe out of step with the US. Journal of the International Association of Physicians in AIDS Care, 1996, Volume: 2, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Didanosine; Drug Costs; Europe; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Quinolines; Ritonavir; Saquinavir; Thiazoles; United States; Valine; Zalcitabine; Zidovudine	1996
Nipping HIV in the bud. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:8 Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication; Zalcitabine; Zidovudine	1996
Efficacies of beta-L-D4A against Hepatitis B virus in 2.2.15 cells. World journal of gastroenterology, 2008, Feb-28, Volume: 14, Issue:8 Topics: Antiviral Agents; Cell Line; Dideoxyadenosine; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Models, Chemical; Tetrazolium Salts; Thiazoles; Virus Replication	2008
Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11 Topics: Animals; Antiviral Agents; Cell Line; DNA, Viral; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Lamivudine; Male; Mice; Mice, Nude; Microbial Sensitivity Tests; Primary Cell Culture; Pyridines; Pyrimidines; Thiazoles; Viral Core Proteins; Viremia; Virion; Virus Replication	2013
Synergistic Interactions between Hepatitis B Virus RNase H Antagonists and Other Inhibitors. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3 Topics: Allosteric Regulation; Antiviral Agents; Deoxycytidine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Gene Expression; Hep G2 Cells; Hepatitis B virus; Humans; Isoquinolines; Kinetics; Lamivudine; Ribonuclease H; Tetrazolium Salts; Thiazoles; Tropolone; Viral Proteins; Virus Replication	2017